Editas Medicine, Inc. (EDIT)
2.85
-0.05
(-1.72%)
USD |
NASDAQ |
Oct 12, 10:58
Editas Medicine Net Income (TTM) : -73.95M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -73.95M |
| March 31, 2026 | -108.95M |
| December 31, 2025 | -160.06M |
| September 30, 2025 | -199.84M |
| June 30, 2025 | -236.86M |
| March 31, 2025 | -251.23M |
| December 31, 2024 | -237.09M |
| September 30, 2024 | -210.57M |
| June 30, 2024 | -193.45M |
| March 31, 2024 | -166.13M |
| December 31, 2023 | -153.22M |
| September 30, 2023 | -195.08M |
| June 30, 2023 | -205.79M |
| March 31, 2023 | -218.95M |
| December 31, 2022 | -220.43M |
| September 30, 2022 | -201.13M |
| June 30, 2022 | -184.49M |
| March 31, 2022 | -186.29M |
| December 31, 2021 | -192.50M |
| September 30, 2021 | -213.56M |
| June 30, 2021 | -166.66M |
| March 31, 2021 | -134.98M |
| Date | Value |
|---|---|
| December 31, 2020 | -115.98M |
| September 30, 2020 | -91.25M |
| June 30, 2020 | -132.01M |
| March 31, 2020 | -142.22M |
| December 31, 2019 | -133.75M |
| September 30, 2019 | -121.03M |
| June 30, 2019 | -103.33M |
| March 31, 2019 | -108.26M |
| December 31, 2018 | -109.95M |
| September 30, 2018 | -121.09M |
| June 30, 2018 | -132.45M |
| March 31, 2018 | -120.17M |
| December 31, 2017 | -120.32M |
| September 30, 2017 | -123.51M |
| June 30, 2017 | -117.93M |
| March 31, 2017 | -110.54M |
| December 31, 2016 | -97.18M |
| September 30, 2016 | -70.44M |
| June 30, 2016 | -56.82M |
| March 31, 2016 | -85.35M |
| December 31, 2015 | -72.90M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Recursion Pharmaceuticals, Inc. | -518.88M |
| Geron Corp. | -69.89M |
| Halozyme Therapeutics, Inc. | 413.60M |
| Novavax, Inc. | -247.73M |
| AVITA Medical, Inc. | -43.08M |